DAIC

MARCH 27, 2024

The registry will collect multi-site, real-world information on how the Plaque Analysis product provides enhanced patient insights, empowering physicians and helping to inform their medical management decisions for patients with suspected coronary artery disease (CAD). Observed outcomes and biomarkers are secondary endpoints.

Coronary Artery Disease 111

Coronary Artery Disease Plaque Technology Anatomy 111

Dr. Paddy Barrett

DECEMBER 19, 2023

Reversing or regressing coronary artery disease is possible. But can coronary artery disease be reversed with lifestyle measures, including changes to nutrition and exercise? In summary, the best outcome for plaque is to: Decrease in size Change from non calcified to calcified Develop a thick fibrous cap.

Coronary Artery Disease 105

Coronary Artery Disease Plaque Exercise Heart Attack 105

Cardiovascular Diabetology

MAY 30, 2024

Ischemia and no obstructive coronary artery disease (INOCA) is increasingly recognized and associated with poor outcomes. The triglyceride-glucose (TyG) index is a reliable alternative measure of insulin resis.

Coronary Artery Disease 59

Coronary Artery Disease Ischemia Outcomes Research 59

Cardiovascular Diabetology

AUGUST 6, 2024

Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Information on GLD (dispended 6 months before or after coronary angiography) was collected from the Swedish Prescribed Drug Registry.

Coronary Artery Disease 98

Coronary Artery Disease Diabetes Myocardial Infarction Heart Failure 98

Medical Xpress - Cardiology

SEPTEMBER 3, 2024

Performing percutaneous coronary intervention (PCI) significantly improved outcomes in patients with stable coronary artery disease (CAD) and severe aortic stenosis selected for transcatheter aortic valve implantation (TAVI), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

Coronary Artery Disease 40

Coronary Artery Disease Aortic valve Aortic Stenosis 40

Circulation

NOVEMBER 11, 2024

However, the long-term outcomes in patient with an intermediate stenosis received FFR have not yet been investigated comprehensively.Methods:We retrospective included 558 patients underwent both coronary artery angiography (CAG) and FFR. Circulation, Volume 150, Issue Suppl_1 , Page A4144277-A4144277, November 12, 2024.

Coronary Artery Disease 40

Coronary Artery Disease Stenosis Risk Factors Outcomes 40

DAIC

MAY 14, 2024

Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare’s interventional cardiology portfolio built around the Allia Platform. Accessed May 2024. Leon, Shubin Qiao, Gregg W.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

Frontiers in Cardiovascular Medicine

JANUARY 31, 2024

Objective In patients with complex coronary artery disease (CAD) undergoing cardiac surgery, myocardial protection might be impaired due to microvascular obstruction, resulting in myocardial injury and subsequent biomarker release.

Coronary Artery Disease 64

Coronary Artery Disease Biomarkers Outcomes 64

Circulation

NOVEMBER 11, 2024

A meta-analysis was performed on primary outcomes of major adverse cardiac events (MACE) and all-cause mortality. A random-effects model was used for outcomes with high heterogeneity.Results:We included 4 RCTs with 3173 patients comparing FFR-guided CR with culprit-only PCI in patients with STEMI and multivessel coronary artery diseases.

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction STEMI Thrombosis 40

Journal of Cardiothoracic Surgery

JUNE 30, 2024

In patients with unprotected left main coronary artery disease (ULMCAD), this study compared the long-term prognosis of drug-eluting stent insertion guided by intravascular ultrasonography (IVUS) vs. angiography.

Coronary Artery Disease 40

Coronary Artery Disease Stent Stents Outcomes 40

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

ObjectivesRevascularization in patients with severely reduced left ventricular function and coronary artery disease (CAD) is associated with a high perioperative risk.

Coronary Artery Bypass Graft 59

Coronary Artery Bypass Graft Coronary Artery Disease Heart Failure Myocardial Infarction 59

Heart BMJ

FEBRUARY 23, 2024

Coronary physiology assessment, including epicardial and microvascular investigations, is a fundamental tool in the contemporary management of patients with coronary artery disease. Coronary revascularisation guided by functional evaluation has demonstrated superiority over angiography-only-guided treatment.

Coronary Artery Disease 53

Coronary Artery Disease Physiology Coronary Artery Bypass Graft Quality of Life 53

Journal of the American Heart Association

DECEMBER 8, 2023

BackgroundLiterature suggests a bidirectional association between advanced hepatic fibrosis (AHF) and coronary artery disease (CAD). We evaluated the association of AHF with immune activation, systemic inflammation, and adverse outcomes in patients with CAD.Methods and ResultsA fibrosis‐4 index cutoff value ≥2.67

Coronary Artery Disease 40

Coronary Artery Disease Outcomes Heart Failure Circulation 40

Coronary Artery Disease Journal

SEPTEMBER 24, 2024

Introduction Despite advancements in coronary artery disease (CAD) management, major adverse cardiovascular events persist. Primary outcomes included myocardial infarction, stroke, major bleeding events, and all-cause mortality. Vitamin K antagonists and direct oral anticoagulants present bleeding risks.

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction Strokes Stroke 40

Circulation

NOVEMBER 11, 2024

We evaluated patterns of evidence-based prescription of SGLT2i and GLP1RA over time and by race in US Veterans with T2D and coronary artery disease (CAD).Results:Of

Coronary Artery Disease 40

Coronary Artery Disease Diabetes Circulation Outcomes 40

Cardiovascular Diabetology

JANUARY 5, 2024

The role of triglyceride-glucose (TyG) index, an insulin resistance indicator, in glycemic management for diabetic patients with coronary artery disease (CAD) was still unknown. Therefore, we aimed to explore.

Coronary Artery Disease 40

Coronary Artery Disease Diabetes Outcomes Research 40

European Journal of Heart Failure

OCTOBER 5, 2023

In this study, two independent cohorts were used to investigate for cardiovascular magnetic resonance (CMR) and genetic features of dilated cardiomyopathy (DCM) in individuals with coronary artery disease (CAD). NI-LGE was not independently associated with adverse clinical outcomes. vs. 6.7%, odds ratio 1.5,

Coronary Artery Disease 40

Coronary Artery Disease Cardiomyopathy Outcomes Myocardial Infarction 40

Journal of the American Heart Association

JANUARY 19, 2024

Journal of the American Heart Association, Ahead of Print. BackgroundCurrent guidelines recommend revascularization in patients with ischemic cardiomyopathy (ICM). CABG and PCI had comparable 30‐day risk‐adjusted mortality risks.

Coronary Artery Disease 40

Coronary Artery Disease Coronary Artery Bypass Graft Cardiomyopathy Stenosis 40

Cardiology Update

MARCH 25, 2024

Left main coronary artery disease (CAD) and diabetes pose significant challenges in cardiovascular care, often leading to adverse outcomes. Preliminary evidence from trials focusing on patients with multivessel disease has hinted at diabetes as a potential modifier of treatment outcomes. Circulation.

Diabetes 122

Diabetes Coronary Artery Bypass Graft Outcomes Coronary Artery Disease 122

Coronary Artery Disease Journal

JUNE 30, 2024

Background This study investigated the relationship between coronary artery disease–reporting and data system (CAD-RADS) for coronary computed tomography angiogram (CCTA) and major adverse cardiovascular and cerebral event (MACE) in a symptomatic Southeast Asian, Thai population over a 5-year period.

Coronary Artery Disease 40

Coronary Artery Disease Heart Failure Outcomes Hospital 40

Circulation

NOVEMBER 6, 2023

Background:Randomized trials in obstructive coronary artery disease (CAD) have largely shown no prognostic benefit from coronary revascularization. We identified the presence and cause of cardiomyopathy using CMR and coronary angiography data, blinded to clinical outcomes. Circulation, Ahead of Print.

Coronary Artery Disease 40

Coronary Artery Disease Cardiomyopathy Hospital Outcomes 40

Med Page Today

APRIL 10, 2024

(MedPage Today) -- ATLANTA -- Fractional flow reserve (FFR)-guided complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease did not result in better outcomes compared.

Coronary Artery Disease 64

Coronary Artery Disease Myocardial Infarction Outcomes STEMI 64

Open Heart

JANUARY 6, 2022

Colchicine, a cheap and widely used anti-inflammatory has shown promise in improving cardiovascular outcomes. We aimed to perform a systematic review and meta-analysis to study the effects of colchicine in patients with symptomatic coronary artery disease (CAD) who have undergone PCI.

Coronary Artery Disease 52

Coronary Artery Disease Thrombosis Stent Stents 52

Cardiology Update

JANUARY 28, 2024

The optimal management of concomitant chronic obstructive coronary artery disease (CAD) in transcatheter aortic valve replacement (TAVR) recipients remains a debated topic. While some advocate for pre-TAVR percutaneous coronary intervention, others adopt an expectant approach. Original article: Persits I et al.

TAVR 115

TAVR Aortic valve Outcomes Coronary Artery Disease 115

The American Journal of Cardiology

OCTOBER 23, 2024

Publication date: Available online 22 October 2024 Source: The American Journal of Cardiology Author(s): Pier Pasquale Leone, Samantha Sartori, Jonathan Murphy, Kenneth Smith, Angelo Oliva, Mauro Gitto, Benjamin Bay, Anastasios Roumeliotis, Birgit Vogel, David Power, Anton Camaj, Francesca Maria Di Muro, Annapoorna Kini, Samin Sharma, Roxana Mehran, (..)

Coronary Artery Disease 40

Coronary Artery Disease Outcomes 40

American College of Cardiology

NOVEMBER 13, 2024

What are clinical outcomes among patients with severe aortic stenosis (AS) and coronary artery disease (CAD) undergoing surgical aortic valve replacement (SAVR) plus revascularization versus transcatheter aortic valve replacement (TAVR) plus percutaneous coronary intervention (PCI)?

Aortic valve 58

Aortic valve Coronary Artery Disease TAVR Aortic 58

Open Heart

JANUARY 21, 2022

Deficits in health literacy are common in patients with coronary artery disease (CAD), and this is associated with increased morbidity and mortality. Five studies targeted interaction between patients and the health system; four of these reported improved outcomes, including through use of teach-back.

Coronary Artery Disease 52

Coronary Artery Disease Outcomes 52

Science Daily - Heart Disease

AUGUST 15, 2024

Researchers have uncovered a significant genetic connection between Alzheimer's disease (AD) and several coronary artery disease (CAD) related disorders and lipid classes, offering opportunities to improve health outcomes across two of the more common causes of death in Australia.

Coronary Artery Disease 98

Coronary Artery Disease Heart Disease Research Outcomes 98

Medical Xpress - Cardiology

AUGUST 15, 2024

Researchers at Edith Cowan University's (ECU's) Centre for Precision Health have uncovered a significant genetic connection between Alzheimer's disease (AD) and several coronary artery disease (CAD) related disorders and lipid classes, offering opportunities to improve health outcomes across two of the more common causes of death in Australia.

Research 95

Research Coronary Artery Disease Heart Disease Outcomes 95

American College of Cardiology

APRIL 26, 2024

Since limb events are major drivers of morbidity in diabetic patients with peripheral (PAD) and coronary artery disease (CAD), does the addition of ticagrelor to background therapy of aspirin improve limb events?

Diabetes 69

Diabetes Coronary Artery Disease Outcomes Article 69

Cardiovascular Diabetology

JANUARY 21, 2024

The triglyceride-glucose (TyG) index is regarded as a dependable alternative for assessing insulin resistance (IR), given its simplicity, cost-effectiveness, and strong correlation with IR. The relationship be.

Coronary Artery Disease 52

Coronary Artery Disease Outcomes Research 52

Circulation

NOVEMBER 11, 2024

We aimed to investigate the impact of albumin levels and their changes on clinical outcomes among patients who were admitted to intensive care units due to cardiac causes.Methods:This is a retrospective, single-center, cohort study. Consecutive patients admitted to coronary care unit (CCU) were enrolled between January 2011 and December 2020.

Outcomes 40

Outcomes Coronary Artery Disease Heart Failure Arrhythmia 40

Cardiovascular Diabetology

MAY 31, 2024

Coronary three-vessel disease (CTVD) accounts for one-third of the overall incidence of coronary artery disease, with heightened mortality rates compared to single-vessel lesions, including common trunk lesion.

Coronary Artery Disease 64

Coronary Artery Disease Outcomes Research 64

Cardiovascular Diabetology

FEBRUARY 2, 2024

The outcomes of percutaneous coronary intervention (PCI) in diabetic patients are still suboptimal, and it is unclear if diabetic patients might derive a benefit from the use of drug-coated balloons.

Coronary Artery Disease 52

Coronary Artery Disease Diabetes Outcomes Research 52

Circulation

OCTOBER 5, 2023

After coronary computed tomography angiography, patients with unobstructed coronary arteries, and who consented, underwent invasive endotyping. μg/mL; 2 mL/min for 2 minutes) to assess for microvascular and coronary spasm.

Angina 40

Angina Coronary Artery Disease Circulation Hospital 40

Cardiovascular Diabetology

APRIL 1, 2024

Atherogenic index of plasma (AIP) represents a novel marker in the current era of cardiovascular diseases. In this meta-analysis, we aimed to evaluate the association of AIP with cardiovascular prognosis in pa.

Coronary Artery Disease 40

Coronary Artery Disease Cardiovascular Disease Outcomes 40

The American Journal of Cardiology

DECEMBER 13, 2023

Publication date: Available online 19 November 2023 Source: The American Journal of Cardiology Author(s): Yuko Kiyohara, Tadao Aikawa, Keigo Kayanuma, Hisato Takagi, Polydoros N. Kampaktsis, Jose Wiley, Toshiki Kuno

Coronary Artery Disease 40

Coronary Artery Disease Outcomes 40